Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system
Nature Medicine2003Vol. 9(3), pp. 287–293
Citations Over TimeTop 10% of 2003 papers
Shirley ShiDu Yan, Zhi‐Ying Wu, Huiping Zhang, Gláucia De Camargo Furtado, Xi Chen, Shi Fang Yan, Ann Marie Schmidt, Chris Brown, Alan Stern, Juan J. Lafaille, Leonard Chess, David M. Stern, Hong Jiang
Related Papers
- → Cutting Edge: C3, a Key Component of Complement Activation, Is Not Required for the Development of Myelin Oligodendrocyte Glycoprotein Peptide-Induced Experimental Autoimmune Encephalomyelitis in Mice(2001)88 cited
- → Gender does not influence the susceptibility of C57BL/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein(2002)73 cited
- → MYMD-1, a novel alkaloid compound, ameliorates the course of experimental autoimmune encephalomyelitis(2019)6 cited
- → Dependency of Experimental Autoimmune Encephalomyelitis Induction on MOG35–55 Properties Modulating Matrix Metalloproteinase-9 and Interleukin-6(2015)2 cited
- → Modeling Multiple Sclerosis in the Two Sexes: MOG<sub>35-55</sub>-Induced Experimental Autoimmune Encephalomyelitis(2023)